🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Spain / NCT06611969
Active, not recruiting Not applicable

Inspiratory Muscle Training in Amateur Athletes

NCT06611969 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2024-09-26
Last updated
2025-03-26

Condition(s) studied

Amateur Athletes

Investigational drug(s) / intervention(s)

ExerciseExercise

Exercise: The training programme will consist of 5 weekly sessions of aerobic work, strength and mobility, plus specific training of the inspiratory muscles, 3 times a week, at a load between 50 and 80% of the maximum inspiratory pressure of each participant, after re-education of their diaphragmatic ventilation.

Exercise: The training programme will consist of 5 weekly sessions of aerobic work, strength and mobility.

Study summary

The main objective of the study is to study the changes in FEV1 with the introduction of the specific inspiratory muscle training programme in the training programme of the popular athletes included. In addition, the secondary aims are to observe the differences in the respiratory capacities of the patients, in the vital signs, VO2 max, respiratory frequency and cardiac variability, as well as to assess the running performance of the participants.

Participants will be assigned to one of 2 study groups: IMT group (n=20) or not-IMT group (n=20) The IMT group will perform inspiratory muscle training in conjunction with the conventional marathon training plan. The not-IMT group will follow only the conventional marathon training plan. The study will be conducted over a 12 week period.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Individuals willing to follow the 16-week running training plan * Possibility of combining aerobic training with inspiratory muscle training * Previous half marathon runner Exclusion Criteria: * \- Exclusive or professional dedication to athletics * Previous or current use of respiratory muscle training. * Inadequate or health risk physical condition * Significant chronic cardiorespiratory diagnoses (e.g. moderate-severe COPD). * Neurological, muscular or neuromuscular problems that interfere with the ability to participate in tests and training protocols. * Discontinuity in the performance of training. * A terminal illness or any other major medical contraindication * Lack of informed consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Valencia Valencia Spain

More University of Valencia trials in Spain

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06611969 on ClinicalTrials.gov ↗ ← All trials in Spain